Loading viewer...
investor_presentation
Format: PDF investor_presentation
1 © 2017 IDEXX Laboratories, Inc. All rights reserved. The IDEXX Opportunity Brian McKeon, Executive Vice President and CFO Bank of America Merrill Lynch Global Healthcare Conference London I September 13, 2017
1 © 2017 IDEXX Laboratories, Inc. All rights reserved.
The IDEXX Opportunity
Brian McKeon, Executive Vice President and CFO
Bank of America Merrill Lynch Global Healthcare Conference
London I September 13, 20172 © 2017 IDEXX Laboratories, Inc. All rights reserved.
Safe Harbor Disclaimer
The following information contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements are based on management ’s current expectations and beliefs, as well as a number of assumptions concerning future
events. These statements are subject to risks, uncertainties, assumptions and other important factors. You are cautioned not to put undue
reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by
the Company pursuant to United States securities laws contain discussions of these risks and uncertainties. The Company assum es no
obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information,
future events or otherwise. You are advised to review the Company ’s filings with the United States Securities and Exchange Commission (which
are available from the SEC ’s EDGAR database at www.sec.gov and via the Company ’s website at www.idexx.com ).
We refer in this presentation to 2017 outlook communicated on August 1, 2017; these references speak only as of August 1, 2017 and shall not
be deemed to be a reiteration or affirmation of the guidance or an indication that our expectations have not changed since that time.
Non-GAAP Financial Measures
In this presentation, we refer to some non-GAAP financial measures. For a reconciliation to the most comparable GAAP financial m easures, we
refer you to our footnotes and the Appendix to this presentation, which also refer to our Definitive Proxy Statement filed March 23, 2017 and
Annual Report on Form 10-K for the year ended December 31, 2016, both of which are available at http://www.idexxproxymaterials.com .
Please refer to additional footnotes in the Appendix. 3 © 2017 IDEXX Laboratories, Inc. All rights reserved.
IDEXX Serves Exceptionally Attractive Spaces
Pet Health Livestock HealthWater Quality4 © 2017 IDEXX Laboratories, Inc. All rights reserved.
Core Business Characteristics
•Global market leadership –
grounded in innovation
•Robust underlying market
•High-margin, durable
recurring revenue streams
The Hartford Financial Services Group Investor Presentation — April 2022
investor_presentationinvestor_presentation
27 Pages
The Hartford Financial Services Group, Inc.
•Strong cash generationStrong Growth Driven By Consistent Focus on Core Businesses
Preview truncated — download the full document for the complete content.
investor_presentation
96 Pages
IDEXX Laboratories Investor Presentation 2023 | Raymond James Conference
conferenceconference
31 Pages
Bank of Georgia Group
investor_presentation
Pacific Nickel Mines
Westpac New Zealand Perpetual Preference Shares Offer 2024
investor_presentationinvestor_presentation
21 Pages
Westpac New Zealand Limited